drugset / Trial / NCT02031016

Remifentanil vs Fentanyl During Cardiac Surgery and Chronic Thoracic Pain

NCT02031016 ↗

Phase 4 Completed 126 enrolled St. Antonius Hospital
RandomizedParallel-groupSingle-blindPrevention

Summary

This study will investigate the influence of intra-operative use of remifentanil versus fentanyl on the percentage of patients with chronic thoracic after cardiac surgery via sternotomy. Secondary quantitative sensory testing is performed to determine thermal and electrical detection and pain threshold and the difference in pain variability scoring. Postoperative pain scores, analgesic use, genetic variances and costs are measured.

Timeline

Start
2014-02
Primary completion
2016-04
Completion
2016-04

Drugs

EvaluationDrugModalityDoseRoute
Comparator Fentanyl Other / unclassified 200 ug Intravenous
Comparator Fentanyl Other / unclassified 500 ug Intravenous
Comparator Remifentanil Small molecule 0.15 ug/kg —

Indications